1. Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?
    Enrico Lucarelli et al, 2023, Cancers CrossRef
  2. Self-defense of human sarcoma cells against cytolytic lymphoid cells of their host
    Joseph G Sinkovics et al, 2021, European Journal of Microbiology and Immunology CrossRef
  3. Combination of Bevacizumab and Dual Immunotherapy for Extensive-Disease Small-Cell Lung Cancer: A Case Report
    Lei Song et al, 2021, Immunotherapy CrossRef
  4. Anti-angiogenesis Revisited: Combination with Immunotherapy in Solid Tumors
    Alex Chambers et al, 2021, Current Oncology Reports CrossRef
  5. Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives
    Silvia Vanni et al, 2022, Therapeutic Advances in Medical Oncology CrossRef
  6. Gemcitabine-Containing Chemotherapy for the Treatment of Metastatic Myxofibrosarcoma Refractory to Doxorubicin: A Case Series
    Arielle Elkrief et al, 2021, Current Oncology CrossRef
  7. Subkutaner Knoten am Unterschenkel eines 87-jährigen Mannes
    F. Mitri et al, 2021, Der Hautarzt CrossRef
  8. Biology and Management of High-Grade Myxofibrosarcoma: State of the Art and Future Perspectives
    Jun Nishio et al, 2023, Diagnostics CrossRef
  9. Hemophagocytic Lymphohistiocytosis as a complication of immune checkpoint inhibitor therapy for sarcoma
    Charles Kenworthy et al, 2022, Current Problems in Cancer: Case Reports CrossRef
  10. Immune Checkpoint Inhibitors and Anti-Angiogenic Therapy for Cancer
    Antonio G. Solimando et al, 2023, Handbook of Cancer and Immunology CrossRef
  11. Pd-1, Pd-L1, Ido, Cd70 and Microsatellite Instability as Potential Targets to Prevent Immune Evasion in Sarcomas
    Vasiliki Siozopoulou et al, 2023, Immunotherapy CrossRef